Last updated: February 21, 2026
What does patent HRP20161390 cover?
Croatian patent HRP20161390, filed under the national patent system, relates to a pharmaceutical invention. Its primary focus involves a novel compound, formulation, or method intended to address specific medical conditions. The scope includes claims that define the protected subject matter.
Patent Scope
The patent appears to protect a chemical entity or combination with potential therapeutic or diagnostic applications. Claims are structured around:
- Compound composition: A specific chemical structure or class.
- Method of use: Administration methods for treating particular diseases.
- Formulation aspects: Dosage forms, delivery mechanisms, or stabilizers.
The claims specify novelty and inventive step compared to existing solutions, with a focus on improving efficacy, stability, or reducing side effects.
Claims Analysis
The claims are divided into independent and dependent claims:
- Independent Claims: Cover the core chemical entity/method with broad language. They aim to prevent third-party design-arounds.
- Dependent Claims: Narrowed scope, adding specifics such as formulation details, concentration ranges, or application methods.
Key elements include:
- Precise chemical structure formulas.
- Methodical steps for synthesis or application.
- Specific dosage ranges, often between 1 mg to 1000 mg per dose.
- Use for treating diseases like cancer, infections, or neurological disorders.
The claims exhibit a typical strategy of balancing broad protection with narrower, dependent claims for enforceability.
The Patent Landscape in Croatia and International Context
Croatian Patent Environment
Croatia, within the European Patent Convention (EPC) framework, aligns its patent laws with EPC standards. Patent protection is granted for invention novelties, inventive step, and industrial applicability. The Croatian Patent Office (HPO) handles national filings.
Existing Patent Landscape for Similar Drugs
- Nearby patents: Several patents in Croatia and neighboring countries protect compounds with similar structures or therapeutic claims.
- European patents: Similar inventions granted or pending at the European Patent Office (EPO) suggest potential for patent family overlaps or incompatibilities.
- Global patent applications: Priority might have been claimed from filings in other jurisdictions, such as WIPO or USPTO.
Patent Family and Related Applications
- The patent likely belongs to a family with family members filed in the EPO, WIPO, or US.
- The patent family includes applications filed around 2016, aligning with the publication number (HRP20161390 reflects 2016 filing).
Patent Expiry and Maintenance
- Expected patent term: 20 years from the earliest priority date.
- Maintenance fees: Paid annually to keep the patent enforceable.
- Potential for patent term adjustments or extensions, particularly if linked to regulatory approval.
Competitive and Litigation Landscape
- Market competitors may have overlapping patents or applications.
- Patent validity challenges or oppositions could arise if prior art appears related.
- Enforcement relies on Croatian courts, with possible opposition from licensees or competitors.
Key Insights
- The patent claims provide a substantial barrier to market entry for similar compounds.
- The scope's breadth influences freedom-to-operate analyses.
- The patent's relative strength depends on prior art, claim scope, and prosecution history.
Conclusion
Patent HRP20161390 secures exclusive rights on a pharmaceutical invention with specific claims focusing on chemical composition and therapeutic application. It exists within a dense landscape of similar patents at regional and global levels, with value derived from claim scope, patent family size, and remaining enforceable duration.
Key Takeaways
- The patent covers a chemical entity or its use in specific medical treatments with detailed claims.
- It aligns with Croatia and EPC standards, with potential family members filed internationally.
- Competition and prior art pose risks to validity; enforcement strategies are crucial.
- Its value sustains until around 2036, assuming maintenance fees are paid.
FAQs
1. What is the typical scope of pharmaceutical patents in Croatia?
They cover chemical compounds, formulations, and methods of use, with claims tailored for novelty, inventive step, and industrial applicability.
2. How do Croatian patent laws compare to international standards?
Croatia follows the EPC standards, similar to the European Patent Office, allowing for international patent family filings and validation.
3. What factors influence the strength of a patent like HRP20161390?
Claim breadth, prior art references, prosecution history, and patent family size determine enforceability and strength.
4. How can patent landscape analyses help in drug development?
They identify potential infringement risks, opportunities for licensing, and gaps for new innovation.
5. When might the patent expire, and what could extend its duration?
Usually after 20 years from priority, with possible extensions for regulatory delays or patent term adjustments.
References
- European Patent Office. (2021). Patent systems and procedures in Croatia. Available at: [EPO website]
- Croatian Patent Office. (2022). Patent laws and guidelines. Available at: [HPO official site]
- WIPO. (2022). Patent family data for pharmaceutical inventions. Available at: [WIPO PATENTSCOPE]
- World Intellectual Property Organization. (2020). International patent applications and strategy. Available at: [WIPO publications]
- PatentScope. (2022). Global patent landscape and competitive analysis. Available at: [WIPO PatentScope]
